CQDM. We share.
Canadian health science companies are invited to submit an expression of interest to pitch in person to global investors at the 2024 OBIO® Investment Summit (OIS) in Toronto on February 14–16, 2024.
Selected Canadian health science companies seeking their next raise and demonstrating high growth potential and readiness for investment will pitch virtually to global investors and strategics. At the last Summit, 40% of the presenting companies were based outside of Ontario.
Since 2018, over 200 Canadian health science companies have presented at the OBIO Investment Summit and the companies that have presented have raised over $1.6 billion in investment and over $2 billion in mergers & acquisitions and licensing.
Please submit your application before October 8, 2023 here: https://www.obio.ca/
2024 OBIO Investment Summit
Related news
News from the industry
Our News
New funding opportunity for RNA therapies!
News from the industry
Our News
CQDM announces the creation of a biomanufacturing services platform to boost expertise in Quebec and accelerate the development of RNA therapies
News from the industry
Our News
CQDM announces a new initiative to stimulate innovation and entrepreneurship in the RNA therapy sector in Quebec